Search | Nursing VHL Search Portal

1.

HER2 testing in metastatic breast cancer - Is reflex ISH testing necessary on HER2 IHC-equivocal (2+) cases?

Liwski, Christopher R; Castonguay, Mathieu C; Barnes, Penny J; Rayson, Daniel; Bethune, Gillian C.

Ann Diagn Pathol ; 59: 151953, 2022 Aug.

Article in English | MEDLINE | ID: mdl-35487077

2.

Independent primary cutaneous and mammary apocrine carcinomas with neuroendocrine differentiation: Report of a case and literature review.

DeCoste, Ryan C; Carter, Michael D; Barnes, Penelope J; Andea, Aleodor A; Wang, Min; Rayson, Daniel; Walsh, Noreen M.

J Cutan Pathol ; 48(11): 1397-1403, 2021 Nov.

Article in English | MEDLINE | ID: mdl-34152024

3.

Primary large cell neuroendocrine carcinoma of the skin: An under-recognized entity and a mimic of metastatic disease.

Lano, Ian Marie; Rayson, Daniel; Arnason, Thomas; Walsh, Noreen M G.

J Cutan Pathol ; 45(1): 54-58, 2018 Jan.

Article in English | MEDLINE | ID: mdl-28960456

4.

Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2- Advanced Breast Cancer.

Pritchard, Kathleen I; Chia, Stephen K; Simmons, Christine; McLeod, Deanna; Paterson, Alexander; Provencher, Louise; Rayson, Daniel.

Oncologist ; 22(1): 12-24, 2017 01.

Article in English | MEDLINE | ID: mdl-27864574

5.

An end too soon?

Rayson, Daniel.

CMAJ ; 194(7): E262-E263, 2022 02 22.

Article in English | MEDLINE | ID: mdl-35193865

6.

Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer.

Rayson, Daniel; Lupichuk, Sasha; Potvin, Kylea; Dent, Susan; Shenkier, Tamara; Dhesy-Thind, Sukhbinder; Ellard, Susan L; Prady, Catherine; Salim, Muhammad; Farmer, Patricia; Allo, Ghasson; Tsao, Ming-Sound; Allan, Alison; Ludkovski, Olga; Bonomi, Maria; Tu, Dongsheng; Hagerman, Linda; Goodwin, Rachel; Eisenhauer, Elizabeth; Bradbury, Penelope.

Breast Cancer Res Treat ; 157(1): 109-16, 2016 05.

Article in English | MEDLINE | ID: mdl-27116183

7.

Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?

Skedgel, Chris; Rayson, Daniel; Younis, Tallal.

Support Care Cancer ; 24(1): 387-394, 2016 Jan.

Article in English | MEDLINE | ID: mdl-26081595

8.

Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group.

Singh, Simron; Dey, Chris; Kennecke, Hagen; Kocha, Walter; Maroun, Jean; Metrakos, Peter; Mukhtar, Tariq; Pasieka, Janice; Rayson, Daniel; Rowsell, Corwyn; Sideris, Lucas; Wong, Ralph; Law, Calvin.

Ann Surg Oncol ; 22(8): 2685-99, 2015 Aug.

Article in English | MEDLINE | ID: mdl-25366583

9.

Impact of the 2013 American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 (HER2) testing of invasive breast carcinoma: a focus on tumours assessed as 'equivocal' for HER2 gene amplification by fluorescence in-situ hybridization.

Bethune, Gillian C; Veldhuijzen van Zanten, Daniel; MacIntosh, Rebecca F; Rayson, Daniel; Younis, Tallal; Thompson, Kara; Barnes, Penny J.

Histopathology ; 67(6): 880-7, 2015 Dec.

Article in English | MEDLINE | ID: mdl-25913507

10.

Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study.

Clemons, Mark J; Cochrane, Brandy; Pond, Gregory R; Califaretti, Nadia; Chia, Stephen K L; Dent, Rebecca Alexandra; Song, Xinni; Robidoux, Andre; Parpia, Sameer; Warr, David; Rayson, Daniel; Pritchard, Kathleen I; Levine, Mark N.

Breast Cancer Res Treat ; 146(1): 153-62, 2014 Jul.

Article in English | MEDLINE | ID: mdl-24924416

11.

On Heartbreak in Oncology.

Rayson, Daniel.

Curr Oncol Rep ; 21(1): 7, 2019 01 25.

Article in English | MEDLINE | ID: mdl-30684122

12.

Incidence of febrile neutropenia in early stage breast cancer patients receiving adjuvant FEC-D treatment.

Assi, Hazem; Murray, Joshua; Boyle, Laura; Rayson, Daniel.

Support Care Cancer ; 22(12): 3227-34, 2014 Dec.

Article in English | MEDLINE | ID: mdl-24996828

13.

Trastuzumab beyond progression for HER2 positive metastatic breast cancer: progression-free survival on first-line therapy predicts overall survival impact.

Rayson, Daniel; Lutes, Sarah; Walsh, Gordon; Sellon, Marlene; Colwell, Bruce; Dorreen, Mark; Drucker, Arik; Jeyakumar, Alwin; Younis, Tallal.

Breast J ; 20(4): 408-13, 2014.

Article in English | MEDLINE | ID: mdl-24985529

14.

Is Oncotype DX testing informative for breast cancers with low ER expression? A retrospective review from a biomarker testing referral center.

Loggie, John; Barnes, Penelope J; Carter, Michael D; Rayson, Daniel; Bethune, Gillian C.

Breast ; 75: 103715, 2024 Jun.

Article in English | MEDLINE | ID: mdl-38520994

15.

HER story: the next chapter in HER-2-directed therapy for advanced breast cancer.

Verma, Sunil; Joy, Anil A; Rayson, Daniel; McLeod, Deanna; Brezden-Masley, Christine; Boileau, Jean-François; Gelmon, Karen A.

Oncologist ; 18(11): 1153-66, 2013.

Article in English | MEDLINE | ID: mdl-24212500

16.

Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on "Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29, 9891-9895".

Rayson, Daniel; Gandhi, Sonal; Joy, Anil A; Brezden-Masley, Christine; Gelmon, Karen A; Sehdev, Sandeep; Cescon, David; Chia, Stephen.

Curr Oncol ; 30(5): 5050-5053, 2023 05 16.

Article in English | MEDLINE | ID: mdl-37232839

17.

Impact of the COVID-19 Pandemic on Medical Oncology Workload: A Provincial Review.

Sheridan, Margaret; Colwell, Bruce; Lamond, Nathan W D; Macfarlane, Robyn; Rayson, Daniel; Snow, Stephanie; Wood, Lori A; Ramjeesingh, Ravi.

Curr Oncol ; 30(3): 3149-3159, 2023 03 07.

Article in English | MEDLINE | ID: mdl-36975451

18.

Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective.

Henning, Jan-Willem; Brezden-Masley, Christine; Gelmon, Karen; Chia, Stephen; Shapera, Shane; McInnis, Micheal; Rayson, Daniel; Asselah, Jamil.

Curr Oncol ; 30(9): 8019-8038, 2023 08 30.

Article in English | MEDLINE | ID: mdl-37754497

19.

Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer.

Lamond, Nathan W D; Skedgel, Chris; Rayson, Daniel; Lethbridge, Lynn; Younis, Tallal.

Breast Cancer Res Treat ; 133(3): 1115-23, 2012 Jun.

Article in English | MEDLINE | ID: mdl-22361999

20.

Improving nodal harvest in colorectal cancer: so what?

Porter, Geoffrey A; Urquhart, Robin; Bu, Jingyu; Johnson, Paul; Rayson, Daniel; Grunfeld, Eva.

Ann Surg Oncol ; 19(4): 1066-73, 2012 Apr.

Article in English | MEDLINE | ID: mdl-21969083

Nursing VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export: